Bibliographic Details
| Title: |
4-Anilinoquinazoline-based benzenesulfonamides as nanomolar inhibitors of carbonic anhydrase isoforms I, II, IX, and XII: design, synthesis, in-vitro, and in-silico biological studies. |
| Authors: |
Nada, Hossam1, Elkamhawy, Ahmed1,2, Abdellattif, Magda H.3, Angeli, Andrea4, Chang Hoon Lee1, Supuran, Claudiu T.4, Kyeong Lee1 kaylee@dongguk.edu |
| Superior Title: |
Journal of Enzyme Inhibition & Medicinal Chemistry. 2022, Vol. 37 Issue 1, p994-1004. 11p. |
| Subject Terms: |
*BENZENESULFONAMIDES, *CARBONIC anhydrase inhibitors, *MOLECULAR docking, *STRUCTURE-activity relationships, *ANTINEOPLASTIC agents, *SUZUKI reaction |
| Abstract: |
Human carbonic anhydrase inhibitors (hCAIs) are a key therapeutic class with a multitude of novel applications such as anticonvulsants, topically acting antiglaucoma, and anticancer drugs. Herein, a new series of 4-anilinoquinazoline-based benzenesulfonamides were designed, synthesised, and biologically assessed as potential hCAIs. The target compounds are based on the well-tolerated kinase scaffold (4-anilinoquinazoline). Compounds 3a (89.4 nM), 4e (91.2 nM), and 4f (60.9 nM) exhibited 2.8, 2.7, and 4 folds higher potency against hCA I when compared to the standard (AAZ, V), respectively. A single digit nanomolar activity was elicited by compounds 3a (8.7 nM), 4a (2.4 nM), and 4e (4.6 nM) with 1.4, 5, and 2.6 folds of potency compared to AAZ (12.1 nM) against isoform hCA II, respectively. Structure-activity relationship (SAR) and molecular docking studies validated our design approach that revealed highly potent hCAIs. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Enzyme Inhibition & Medicinal Chemistry is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Premier |